BridgeMD
New treatment option for Acute Stroke
Official title Body Composition and Acute Stroke
ClinicalTrials.gov ID: NCT06589297
What this study is testing
- What it's testing
- Body composition appears to be a prognostic factor for the severity and functional outcome of stroke patients. In this study the prognostic value of two bioimpedance parameters will be studied (skeletal mass index and phase angle) and two temporal muscle measurements (thickness and surface area) to predict the functional outcome of patients at discharge and at 6 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- volunteer stroke patients in acute phase
- Age ≥ 18 years
- Having had a brain MRI
- Able to understand assessment guidelines
- Not having objected to participate in the study after being duly informed
You likely can't join if
- Person under tutorship or curatorship
- Person under court protection
- Persons deprived of their liberty
- Pregnant or breastfeeding women
- Have a pacemaker or defibrillator
The study team makes the final eligibility decision.
Where it's taking place
- Orléans, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Orléans, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.